R. Jacob Vogelstein - Profile and Investment Details

Investor Profile

R. Jacob Vogelstein is a Venture Capital, Founder, Investor based in District of Columbia, United States with a diverse investment portfolio that includes companies such as Immunai, Freenome, Sensei Biotherapeutics, eNeura Therapeutics, ATAI Life Sciences, Paige, Personal Genome Diagnostics, EGenesis, Fractyl Laboratories, Cambrian Biopharma, Glympse Bio, Volastra Therapeutics, SetPoint Medical, Recursion Pharmaceuticals, Faze Medicines, . Over time, R. Jacob Vogelstein has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether R. Jacob Vogelstein is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Women Founded, Life Science, Artificial Intelligence (AI), Analytics, Bioinformatics, Software, Biotechnology, Genomics, Neuroscience, Clinical Trials, Research, Health Diagnostics, Medical, Therapeutics, Machine Learning may find it worthwhile to explore potential connections with R. Jacob Vogelstein, as their portfolio suggests a familiarity and interest in this area.

Understanding R. Jacob Vogelstein’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.